Two Different Questions
The widespread availability of AI-powered protein structure prediction has been transformative for drug discovery. Tools like AlphaFold have made it possible to generate structural models for proteins that lack experimental structures. However, obtaining a structure is only the first step in structure-guided discovery.
Structure prediction is the computational generation of a three-dimensional molecular model from sequence or other input data. The output is a structure—coordinates representing atomic positions.
Structural intelligence is the interpretation of structural information to inform discovery decisions. It encompasses the analytical steps that connect a structure to actionable scientific conclusions.
A predicted structure becomes useful when you can determine what it means for your discovery program—where molecules might bind, whether sites are druggable, and which candidates merit experimental investigation.
What Structure Prediction Provides
Structure prediction methods generate atomic coordinates representing a proposed molecular conformation. Modern deep learning approaches can predict structures with remarkable accuracy for many protein families. The output typically includes:
- Atomic coordinates for the predicted structure
- Confidence scores indicating prediction reliability
- Per-residue quality estimates
- Multiple conformational states in some cases
However, the structure itself does not automatically reveal which regions are suitable for therapeutic intervention, how a potential drug might interact with the protein, or which binding hypotheses deserve experimental testing.
What Structural Intelligence Adds
Structural intelligence encompasses the analytical workflow that transforms a structure into discovery-relevant information:
| Analysis Step | Discovery Question Addressed |
|---|---|
| Structure Quality Assessment | Which regions of this structure are reliable enough for downstream analysis? |
| Binding Site Detection | Where on this structure might molecules bind? |
| Pocket Characterization | What are the geometric and chemical properties of potential binding sites? |
| Druggability Analysis | Are these binding sites suitable for small-molecule or biologic intervention? |
| Molecular Docking | How might candidate molecules interact with these sites? |
| Interaction Analysis | Which molecular features contribute to binding? |
| Candidate Evaluation | Which candidates should advance to experimental testing? |
The Workflow Connection
In practice, structure prediction and structural intelligence form a connected workflow:
Structure → Confidence/QC → Binding Sites → Pockets → Druggability → Docking → Interactions → Candidate Assessment
Each step builds on the previous one. A structure with low-confidence regions may require different handling than a high-confidence experimental structure. Binding sites must be identified before druggability can be assessed. Docking results inform interaction analysis, which supports candidate prioritization.
Why the Distinction Matters
Understanding this distinction has practical implications:
- Tool selection: Structure prediction tools and structural analysis tools serve different purposes and may require different expertise
- Workflow design: A complete structure-guided discovery workflow requires both prediction and interpretation capabilities
- Result interpretation: A predicted structure is not equivalent to a validated binding hypothesis—additional analysis is required
- Platform evaluation: Integrated platforms that connect prediction with downstream analysis can maintain structural context throughout discovery
Explore Structural Intelligence
See how CycloGen connects structure prediction with structural analysis and candidate evaluation.
Explore the Pipeline